大分大学 医学部
消化器内科学講座
教授

村上 和成

専門分野

消化器内科学

所属部署

消化器内科学講座(公式HP

業績

1.    Shiota S, Murakami K, Okimoto T, Kodama M and Yamaoka Y.  Serum Helicobacter pylori CagA antibody titer as a useful marker for advanced inflammation in the stomach in Japan.  J Gastroenterol Hepatol, 29: 67-73, 2014.

2.    Inoue K, Ozaka S, Okamoto K, Ogawa R, Mizukami K, Okimoto T, Kodama M, Kobayashi T, Eshita Y, Hasegawa H and Murakami K.  Multiple infections with helminths--whipworm, hookworm, and roundworm.  Endoscopy, 46 Suppl 1 UCTN: E117-118, 2014.

3 Yamamoto K, Shiota S, Ohno S, Kuroda A, Yoshiiwa A, Abe K, Murakami K and Fujioka T.  A diagnosis of depression should be considered in patients with multiple physical symptoms in primary care clinics.  Tohoku J Exp Med, 229: 279-285, 2013.

4 Tamura A, Murakami K, Kadota J and Investigators O-GS.  Prevalence of gastroduodenal ulcers/erosions in patients taking low-dose aspirin with either 15 mg/day of lansoprazole or 40 mg/day of famotidine: the OITA-GF study 2.  BMC Res Notes, 6: 116, 2013.

5.  Nakagawa Y, Yamauchi M, Ogawa R, Watada M, Mizukami K, Okimoto T, Kodama M, Murakami K and Fujioka T.  Complete pancreas divisum with patulous minor papilla complicated by multifocal branch-duct intraductal papillary mucinous neoplasms.  Endoscopy, 45 Suppl 2 UCTN: E199-200, 2013.

6.  Murakami K, Furuta T, Ando T, Nakajima T, Inui Y, Oshima T, Tomita T, Mabe K, Sasaki M, Suganuma T, Nomura H, Satoh K, Hori S, Inoue S, Tomokane T, Kudo M, Inaba T, Take S, Ohkusa T, Yamamoto S, Mizuno S, Kamoshida T, Amagai K, Iwamoto J, Miwa J, Kodama M, Okimoto T, Kato M, Asaka M and Japan GSG.  Multi-center randomized controlled study to establish the standard third-line regimen for Helicobacter pylori eradication in Japan.  J Gastroenterol, 48: 1128-1135, 2013.

7. Mizukami K, Murakami K, Yamauchi M, Matsunari O, Ogawa R, Nakagawa Y, Okimoto T, Kodama M and Fujioka T.  Evaluation of selective cyclooxygenase-2 inhibitor-induced small bowel injury: randomized cross-over study compared with loxoprofen in healthy subjects.  Dig Endosc, 25: 288-294, 2013.

8. ○Kodama M, Murakami K, Okimoto T, Abe H, Sato R, Ogawa R, Mizukami K, Shiota S, Nakagawa Y, Soma W, Arita T and Fujioka T.  Histological characteristics of gastric mucosa prior to Helicobacter pylori eradication may predict gastric cancer.  Scand J Gastroenterol, 48: 1249-1256, 2013.

9. Shiota S, Nguyen LT, Murakami K, Kuroda A, Mizukami K, Okimoto T, Kodama M, Fujioka T and Yamaoka Y.  Association of helicobacter pylori dupA with the failure of primary eradication.  J Clin Gastroenterol, 46: 297-301, 2012.

10.              Nakagawa Y, Murakami K, Hirashita Y, Ogawa R, Hisamatsu A, Mizukami K, Uchida M, Okimoto T, Kodama M, Urabe S, Kashima K and Fujioka T.  A case of Good syndrome with refractory gastrointestinal ulcers.  Endoscopy, 44 Suppl 2 UCTN: E246-247, 2012.

11.              Mizukami K, Murakami K, Hirashita Y, Hisamatsu A, Ogawa R, Uchida M, Nakagawa Y, Okimoto T, Kodama M and Fujioka T.  Efficacy of rebamipide for low-dose aspirin-related gastrointestinal symptoms.  J Clin Biochem Nutr, 51: 216-220, 2012.

12.              ○Matsunari O, Shiota S, Suzuki R, Watada M, Kinjo N, Murakami K, Fujioka T, Kinjo F and Yamaoka Y.  Association between Helicobacter pylori virulence factors and gastroduodenal diseases in Okinawa, Japan.  J Clin Microbiol, 50: 876-883, 2012.

13.              ○Kodama M, Murakami K, Okimoto T, Sato R, Uchida M, Abe T, Shiota S, Nakagawa Y, Mizukami K and Fujioka T.  Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication.  J Gastroenterol, 47: 394-403, 2012.

14.              ○Kodama M, Murakami K, Okimoto T, Fukuda Y, Shimoyama T, Okuda M, Kato C, Kobayashi I and Fujioka T.  Influence of proton pump inhibitor treatment on Helicobacter pylori stool antigen test.  World J Gastroenterol, 18: 44-48, 2012.

15 ○Kodama M, Murakami K, Okimoto T, Abe T, Nakagawa Y, Mizukami K, Uchida M, Inoue K and Fujioka T.  Helicobacter pylori eradication improves gastric atrophy and intestinal metaplasia in long-term observation.  Digestion, 85: 126-130, 2012.

センスネットに登録する5大メリット

  • 研究費の獲得情報を配信。獲得支援も行っています。
  • コーディネーターが質の高いマッチングを提供。
  • 大分大学のリソースを活用製品化までを最適化出来る。
  • 研究内容や企業PRが可能。コーディネーターが取材
  • 人的ネットワークの構築。アイデアを具現化に最適。
CENSNET センスネットに仮登録する 登録費、年会費は一切かかりません。センスネットは、あなたからの登録を待っています。

お問い合わせ先

ご不明点・ご相談など、お気軽にお問い合わせください。

お問い合わせは、医療機器開発に関するものをお送りください。

疾病、診断の相談は受け付けておりません。